|
DEA
Offices & Telephone Nos.
Washington, D.C.202-305-8500
Norfolk, VA 757-314-2200
Wheeling, WV 304-230-6092
|
State Facts
Population: 571,822
State Prison Population: 3,000
Probation Population: 7,747
Violent Crime Rate
National Ranking: n/a |
2006
Federal Drug Seizures
Cocaine: 64.0 kgs.
Heroin: 12.1 kgs.
Methamphetamine: 0.4 kgs./108 du
Marijuana: 29.0 kgs.
Hashish: 0.0 kgs.
MDMA: 0.0 kgs./31,758 du
Meth Lab Incidents: 0 (DEA, state, and local) |
Drug
Situation: The nation's capital has long been plagued
by a variety of drug problems, most notably the violence associated
with crack cocaine distribution. Street "crews" operating
in open-air markets or on neighborhood corners continue to thrive
in Washington, DC. The city's large international population provides
insulation for ethnic drug trafficking groups from almost every
major supply country in the world and the suburbs surrounding
the city provide a steady supply of customers.
Cocaine: Cocaine
and crack are the most significant drug problems in Washington, DC.
Despite several consecutive years of decline in violent, drug-related
crime, the violence associated with the crack trade in the city remains
high. Open-air markets situated along commuting corridors and within
public housing projects provide dealers with a consistent stream of
customers, either from the neighboring Virginia and Maryland suburbs
or from within the neighborhoods they service.
Heroin:
Although Washington, DC does not house anywhere near the number
of addicts of its metropolitan neighbor Baltimore, the city is home to
a large number of long-term heroin abusers who frequent various open-air
drug markets within the city. The city's heroin suppliers set up heroin
shops specifically catering to a specific user population. The markets
located along commuter routes into the city peddle high purity heroin
to suburban abusers, while the shops situated near methadone clinics
and those co-existing with open-air markets tend to service long-term
addicts with lower purity heroin. In the District of Columbia, heroin
is sold under various street/brand names and is packaged primarily in
small, usually colored or marked, ziploc baggies. Most of the heroin
encountered in Washington, DC is of South American origin, but it is
not unusual to discover heroin from other source areas as well, most
recently Southwest Asian.
PCP:
PCP distribution has increased in the Washington, DC metropolitan area
recently, although availability isn't near the level of cocaine,
crack or heroin. PCP has a long history of higher-than-average levels
of abuse in Washington, DC, but its introduction into the battery
of drugs abused by young adult "ravers" both within the
city and in the surrounding suburbs has contributed to renewed interest
in the dangerous substance.
 Methamphetamine: There
is a very limited market for methamphetamine in the District of Columbia.
What demand exists is centered on the city's thriving rave and nightclub
scene and among the city's gay population. Most of the methamphetamine
available in Washington, DC comes from sources of supply in California
via overnight or regular mail delivery services.
Club
Drugs: Washington, DC's rave scene has thrived
for many years. MDMA, Ketamine, GHB, crystal methamphetamine
and various other hallucinogenic and stimulant drugs have been in demand
and readily available in the District for almost a decade. MDMA abuse
and distribution is at high levels.
Marijuana:
Marijuana is the most widely abused of all drugs in the District, crossing
socioeconomic, age and ethnic lines. It is readily available in
qualities and quantities ranging from "nickel bags" of
loose, commercial-grade product to hundred-pound quantities of high grade
marijuana. The use of marijuana in "blunts" has not diminished
and is often observed taking place openly. Marijuana is often sold
alongside cocaine, crack and heroin in open-air markets.
Pharmaceutical Diversion: Current investigations indicate that diversion of oxycodone products such as OxyContin® continues to be a problem in Washington D.C. Primary methods of diversion being reported are illegal sale and distribution by health care professionals and workers, “doctor shopping” (going to a number of doctors to obtain prescriptions for a controlled pharmaceutical), and forged prescriptions. Hydrocodone products, benzodiazepines, methadone and Percodan®/Percocet® were also identified as being among the most commonly abused and diverted pharmaceuticals in Washington D.C.
DEA
Mobile Enforcement Teams:
This cooperative program with state and local law enforcement counterparts
was conceived in 1995 in response to the overwhelming problem of drug-related
violent crime in towns and cities across the nation. Since the inception of the MET Program, a total of 436 deployments have been completed nationwide, resulting in 18,318 arrests. There has been one MET deployment since
the inception of the program, in Washington, D.C.
DEA
Regional Enforcement Teams:
This program was designed to augment existing DEA division resources
by targeting drug organizations operating in the United States where
there is a lack of sufficient local drug law enforcement. This program
was conceived in 1999 in response to the threat posed by drug trafficking
organizations that have established networks of cells to conduct drug
trafficking operations in smaller, non-traditional trafficking locations
in the United States. As of January 31, 2005, there have been 27 deployments
nationwide, and one deployment in the U.S. Virgin Islands, resulting
in 671 arrests. There have been no RET deployments in the District of
Columbia.
Special
Enforcement Initiatives:
The Washington/Baltimore HIDTA supports and assists in the funding of
a multi-agency enforcement task force and an intelligence group in Washington,
DC. In addition, the Washington, DC Metropolitan Police Department has
its own Major Narcotics Branch, and other drug and violent crime-related
enforcement operations in place.
More about Washington's
Division Office.
Sources
Factsheet
last updated: 2/2007
|